Baird raised the firm’s price target on Stryker to $378 from $367 and keeps an Outperform rating on the shares. The firm said the company delivered a solid start to 2024, with global organic revenue growing double-digits for a fifth quarter in past six, even against the toughest year over year comp the company will encounter this year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK: